TARGET AUDIENCE
This activity is intended for clinical nurse specialists, nurse practitioners and registered nurses.
LEARNING OBJECTIVES
- Apply the oncology principles discussed to the care of patients with breast cancer.
- Explore new supportive and therapeutic strategies to enhance the care of patients with breast cancer.
ACCREDITATION STATEMENT
Research To Practice is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
CREDIT DESIGNATION STATEMENT
This educational activity for 1.5 contact hours is provided by Research To Practice during the period of March 2011 through March 2012.
HOW TO USE THIS CNE ACTIVITY
This CNE activity contains a video component. To receive credit, the participant should watch the video content and complete the Educational Assessment and Credit Form located on our website at ResearchToPractice.com/IOLBreast11/CNE.
CONTENT VALIDATION AND DISCLOSURES
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CNE activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process:
Kimberly L Blackwell, MD
Associate Professor of Medicine
Assistant Professor of Radiation Oncology
Duke University Medical Center
Durham, North Carolina
Consulting Agreements and Speakers Bureau: GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi; Paid Research: Abraxis BioScience Inc, a wholly owned subsidiary of Celgene Corporation, Bristol-Myers Squibb Company, Genentech BioOncology, GlaxoSmithKline.
Una Hopkins, RN, FNP-BC
Administrative Director, Dickstein Cancer Center
White Plains Hospital
White Plains, New York
Speakers Bureau: Bristol-Myers Squibb Company, Eisai Inc, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, Novartis Pharmaceuticals Corporation.
Georgia Litsas, MSN, ANP-BC, AOCNP
Nurse Practitioner, Breast Oncology Center
Dana-Farber Cancer Institute
Boston, Massachusetts
Speakers Bureau: Genentech BioOncology, Novartis Pharmaceuticals Corporation, Pfizer Inc.
Ruth O’Regan, MD
Associate Professor of Hematology and Medical Oncology
Chief of Hematology and Medical Oncology of Georgia Cancer Center for Excellence at Grady Memorial Hospital
Emory University School of Medicine
Winship Cancer Institute
Atlanta, Georgia
Sponsor of Research: Genentech BioOncology; Sponsor of Trial: Abraxis BioScience Inc, a wholly owned subsidiary of Celgene Corporation, Pfizer Inc.
MODERATOR — Dr Love is president and CEO of Research To Practice, which receives funds in the form of educational grants to develop CME/CNE activities from the following commercial interests: Abraxis BioScience Inc, a wholly owned subsidiary of Celgene Corporation, Allos Therapeutics, Amgen Inc, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer HealthCare Pharmaceuticals/Onyx Pharmaceuticals Inc, Biogen Idec, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corporation, Cephalon Inc, Dendreon Corporation, Eisai Inc, EMD Serono Inc, Genentech BioOncology, Genomic Health Inc, Lilly USA LLC, Millennium — The Takeda Oncology Company, Myriad Genetics Inc, Novartis Pharmaceuticals Corporation, OSI Oncology, Sanofi and Seattle Genetics.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.
This program is supported by an educational grant from Genentech BioOncology.
Hardware/Software Requirements:
An Internet connection that is at least 28.8 Kbps
A monitor set to 1280 x 1024 pixels or more
Internet Explorer 6.x or newer, Firefox 2.x or newer, or Safari 2.x or newer
Macromedia Flash plug-in 6.0 or greater
Adobe Acrobat Reader
(Optional) Sound card and speakers for audio
Last review date: March 2011
Expiration date: March 2012
